RECRUITING

An International Observational Study of Adults With Acute Infection

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Prospective, longitudinal studies of people with acute infections are essential to understand risk factors, clinical manifestations, pathobiology, and management strategies. Observational studies can provide data necessary to select interventions and strategies for testing in clinical trials and to develop key design features of trials. Observational studies can be particularly important for establishing an early knowledge base after emergence of a new pathogen, as illustrated by the recent emergence of influenza A (H1N1), SARS-CoV-2, and Mpox. This observational study protocol describes collection of data and biospecimens from sites across the world for characterizing acute infections in hospitalized patients. The protocol is designed to study respiratory infections, infections outside the respiratory tract, established infectious diseases, and emerging infectious diseases. Data generated in this study will be used to efficiently characterize acute infectious diseases and plan future clinical trials.

Official Title

An International Observational Study of Adults With Acute Infection

Quick Facts

Study Start:2025-08-25
Study Completion:2027-06-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07069400

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥18 years old
  2. * Admitted to hospital (or in an emergency department with anticipated hospital admission) for the management of a suspected or confirmed acute infectious disease.
  3. * Onset of symptoms of an infectious disease within the past 30 days.
  4. * Informed consent for study participation by the participant or a surrogate decision maker if the participant lacks capacity for consent.
  1. * Current imprisonment (this does not include quarantine for an infectious disease).
  2. * Patient undergoing comfort care measures only such that treatment focuses on end- of-life symptom management over prolongation of life.
  3. * Expected inability or unwillingness to participate in study procedures.
  4. * In the opinion of the investigator, participation in the study is not in the best interest of the patient.

Contacts and Locations

Study Contact

Rebecca Schoenecker
CONTACT
612-624-9644
webe0376@umn.edu

Principal Investigator

Cavan Reilly, PhD
PRINCIPAL_INVESTIGATOR
University of Minnesota

Study Locations (Sites)

University of Minnesota
Minneapolis, Minnesota, 55414
United States

Collaborators and Investigators

Sponsor: University of Minnesota

  • Cavan Reilly, PhD, PRINCIPAL_INVESTIGATOR, University of Minnesota

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-08-25
Study Completion Date2027-06-08

Study Record Updates

Study Start Date2025-08-25
Study Completion Date2027-06-08

Terms related to this study

Additional Relevant MeSH Terms

  • Infectious Disease